Refine your search
-
Authors
-
Item types
-
Topics
- *Anti-Obesity Agents/ae [Adverse Effects]
- *Antibodies, Monoclonal, Humanized/tu [Therapeutic Use]
- *Brain/de [Drug Effects]
- *Breast Neoplasms/dt [Drug Therapy]
- *Breast Neoplasms/ge [Genetics]
- *Hydrogen Peroxide/tu [Therapeutic Use]
- *Keratosis, Seborrheic/dt [Drug Therapy]
- *Liraglutide/ae [Adverse Effects]
- *Neurotoxicity Syndromes/ep [Epidemiology]
- *Obesity/dt [Drug Therapy]
- *Oxidants/tu [Therapeutic Use]
- *Receptor, erbB-2/ge [Genetics]
- Administration, Topical
- Adult
- Aged
- Anti-Obesity Agents/ad [Administration & Dosage]
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic [x]
- Female
- Humans
- Show more
- Show less
-
Collections
-
Languages